CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 89  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0751
LYS 10.0160
GLU 20.0164
LEU 30.0326
ARG 40.0304
CYS 50.0121
GLN 60.0256
CYS 70.0064
ILE 80.0122
LYS 90.0207
THR 100.0166
TYR 110.0075
SER 120.0168
LYS 130.0217
PRO 140.0084
PHE 150.0063
HIS 160.0078
PRO 170.0126
LYS 180.0088
PHE 190.0095
ILE 200.0040
LYS 210.0111
GLU 220.0064
LEU 230.0090
ARG 240.0177
VAL 250.0349
ILE 260.0211
GLU 270.0023
SER 280.0164
GLY 290.0454
PRO 300.0250
HIS 310.0192
CYS 320.0309
ALA 330.0233
ASN 340.0103
THR 350.0134
GLU 360.0191
ILE 370.0130
ILE 380.0157
VAL 390.0057
LYS 400.0074
LEU 410.0060
SER 420.0159
ASP 430.0332
GLY 440.0123
ARG 450.0230
GLU 460.0150
LEU 470.0142
CYS 480.0099
LEU 490.0122
ASP 500.0177
PRO 510.0081
LYS 520.0326
GLU 530.0055
ASN 540.0127
TRP 550.0240
VAL 560.0117
GLN 570.0193
ARG 580.0180
VAL 590.0099
VAL 600.0075
GLU 610.0127
LYS 620.0171
PHE 630.0056
LEU 640.0134
LYS 650.0280
ARG 660.0134
ALA 670.0224
GLU 680.0499
ASN 690.0751

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.